Cost analysis of schistosomiasis.
Cost analysis of schistosomiasis is important both in assessing the economic impact of the disease and in identifying the most cost-effective approaches to control. Economic impact has been examined both within and without the health sector, but there is a lack of measurement of the effects of disease, or the threat of disease, on patterns of production and community development. The cost-effectiveness of control approaches has been examined empirically and by using static models. Future analyses require a stronger epidemiological basis incorporating realistic demography and the temporal dynamics of reinfection, and assessment of outcomes in terms of disease rather than infection.
Bundy
D A
DA
Wellcome Trust Research Centre for Parasitic Infections, Imperial College, London, UK.
Guyatt
H L
HL
D003362:Cost-Benefit Analysis; D006296:Health Services / Q000191:economics; D006801:Humans; D012552:Schistosomiasis / Q000191:economics* / Q000517:prevention & control